TNNT2 and aortic stenosis: Leveraging prospective biospecimen collection on 89% of participants in the largest randomized strategy trial on optimal timing of AVR in patients with asymptomatic severe AS, this report substantively advances our understanding of the potential role of NT-proBNP and hs-cTnT levels in clinical decision making.